Pfizer has received a certificate from KFin Technologies Limited, Registrar & Share Transfer Agent, confirming compliance with SEBI regulations for the quarter ended September 30, 2025. This certificate ensures adherence to depositories and participants’ regulations. The company has requested that the exchange record the certificate.
Compliance Confirmation
Pfizer has received a certificate dated October 7, 2025, from KFin Technologies Limited, the company’s Registrar & Share Transfer Agent, confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for Q2 (July-September) of 2025.
Details of Certification
The certificate confirms that securities received for dematerialization during the quarter were duly processed and confirmed to the depositories. It also verified that physical share certificates received for dematerialization have been mutilated and canceled following verification by the depository participant. The names of the depositories have been substituted in the register of members as the registered owner within 30 days.
Source: BSE